NCT05523180View on ClinicalTrials.gov

A Study to Evaluate the Effect of Probiotic Supplement on Quality of Life

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

September 12, 2023

Study Completion Date

September 12, 2023

Conditions
Chronic Obstructive Pulmonary DiseaseNon-cystic Fibrosis Bronchiectasis
Interventions
DIETARY_SUPPLEMENT

Probiotic

"Active ingredients:~Lactobacillus plantarum RSB11, 5 Billion colony forming units (CFU) Lactobacillus acidophilus RSB12, 5 Billion CFU Lactobacillus rhamnosus RSB13, 5 Billion CFU Holy basil leaf extract, 42.0 mg Turmeric root extract, 30.0 mg Vasaka leaf extract, 48.0 mg~Inactive ingredients:~Microcrystalline Cellulose, Vegan Capsule (Hypromellose), Magnesium Stearate, Silicon Dioxide"

OTHER

Placebo

"Active ingredients:~N/A~Inactive ingredients:~Microcrystalline Cellulose, Vegan Capsule (Hypromellose), Magnesium Stearate, Silicon Dioxide"

Trial Locations (2)

32162

Premier Medical Associates, The Villages

33186

Coral Research Clinic Corp., Miami

All Listed Sponsors
collaborator

Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

NETWORK

lead

ResBiotic Nutrition, Inc.

INDUSTRY